DE GIORGI, UGO FEDERICO FRANCESCO

DE GIORGI, UGO FEDERICO FRANCESCO  

Mostra records
Risultati 1 - 16 di 16 (tempo di esecuzione: 0.027 secondi).
Titolo Autore(i) Anno Periodico Editore Tipo File
Adjuvant high-dose chemotherapy with autologous hematopoietic stem cell transplantation for high-risk breast cancer: results from the italian National Registry Pedrazzoli, Paolo; Martinelli, Giovanni; Gianni, Alessandro Massimo; Da Prada, Gian Antonio; Ball...estrero, Alberto; Rosti, Giovanni; Frassineti, Giovanni Luca; Aieta, Michele; Secondino, Simona; Cinieri, Saverio; Fedele, Roberta; Bengala, Carmelo; Bregni, Marco; Grasso, Donatella; De Giorgi, Ugo; Lanza, Francesco; Castagna, Luca; Bruno, Barbara; Martino, Massimo; Gruppo Italiano per il Trapianto di Midollo Osseo, Cellule staminali emopoietiche e terapia cellulare 2014-01-01 BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION - 1.01 Articolo in rivista -
An update on our ability to monitor castration-resistant prostate cancer dynamics with cell-free DNA Conteduca V.; Brighi N.; Conteduca D.; Bleve S.; Gianni C.; Schepisi G.; Iaia M.L.; Gurioli G.; L...olli C.; De Giorgi U. 2021-01-01 EXPERT REVIEW OF MOLECULAR DIAGNOSTICS - 1.01 Articolo in rivista -
Circulating Androgen Receptor for Prognosis and Treatment Selection in Prostate Cancer Conteduca V.; Wetterskog D.; Gonzalez-Billalabeitia E.; Brighi N.; De Giorgi U.; Attard G. 2021-01-01 EUROPEAN UROLOGY ONCOLOGY - 1.01 Articolo in rivista -
Clinical outcome of patients who reduced sunitinib or pazopanib during first-line treatment for advanced kidney cancer Iacovelli, Roberto*; Cossu Rocca, Maria; Galli, Luca; De Giorgi, Ugo; Sabbatini, Roberto; Santoni..., Matteo; Mosca, Alessandra; Fornarini, Giuseppe; Massari, Francesco; Masini, Cristina; Bersanelli, Melissa; Biasco, Elisa; Lolli, Cristian; Guida, Annalisa; Berardi, Rossana; Terrone, Carlo; Pastorino, Alessandro; Ardizzoni, Andrea; Pinto, Carmine; Buti, Sebastiano; Nolè, Franco; Tortora, Giampaolo 2017-01-01 UROLOGIC ONCOLOGY - 1.01 Articolo in rivista -
Combining liquid biopsy and functional imaging analysis in metastatic castration-resistant prostate cancer helps predict treatment outcome Conteduca V.; Scarpi E.; Caroli P.; Lolli C.; Gurioli G.; Brighi N.; Poti G.; Farolfi A.; Altavil...la A.; Schepisi G.; Matteucci F.; Paganelli G.; De Giorgi U. 2021-01-01 MOLECULAR ONCOLOGY - 1.01 Articolo in rivista Molecular Oncology - 2021 - Conteduca - Combining liquid biopsy and functional imaging analysis in metastatic.pdfSupplementary materials.zip
Enzalutamide for the treatment of nonmetastatic castration-resistant prostate cancer Altavilla A.; Casadei C.; Lolli C.; Menna C.; Ravaglia G.; Gurioli G.; Farolfi A.; Brighi N.; Con...teduca V.; Burgio S.L.; Schepisi G.; Rossi L.; Gargiulo S.; Lisotti I.; De Giorgi U. 2020-01-01 EXPERT OPINION ON PHARMACOTHERAPY - 1.01 Articolo in rivista -
Flare phenomenon in prostate cancer: recent evidence on new drugs and next generation imaging Conteduca V.; Poti G.; Caroli P.; Russi S.; Brighi N.; Lolli C.; Schepisi G.; Romeo A.; Matteucci... F.; Paganelli G.; Marchetti P.; De Giorgi U. 2021-01-01 THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY - 1.01 Articolo in rivista 1758835920987654.pdf
Immunotherapy and its development for gynecological (Ovarian, endometrial and cervical) tumors: From immune checkpoint inhibitors to chimeric antigen receptor (car)-T cell therapy Schepisi G.; Casadei C.; Toma I.; Poti G.; Iaia M.L.; Farolfi A.; Conteduca V.; Lolli C.; Ravagli...a G.; Brighi N.; Altavilla A.; Martinelli G.; De Giorgi U. 2021-01-01 CANCERS - 1.01 Articolo in rivista cancers-13-00840-v2.pdf
Moving beyond parp inhibition: Current state and future perspectives in breast cancer Palleschi M.; Tedaldi G.; Sirico M.; Virga A.; Ulivi P.; De Giorgi U. 2021-01-01 INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - 1.01 Articolo in rivista ijms-22-07884-v3.pdf
New prognostic biomarkers in metastatic castration-resistant prostate cancer Conteduca V.; Mosca A.; Brighi N.; de Giorgi U.; Rescigno P. 2021-01-01 CELLS - 1.01 Articolo in rivista -
Plasma androgen receptor and response to adapted and standard docetaxel regimen in castration-resistant prostate cancer: A multicenter biomarker study Conteduca V.; Wetterskog D.; Castro E.; Scarpi E.; Romero-Laorden N.; Gurioli G.; Jayaram A.; Lol...li C.; Schepisi G.; Wingate A.; Casadei C.; Lozano R.; Brighi N.; Aragon I.M.; Marin-Aguilera M.; Gonzalez-Billalabeitia E.; Mellado B.; Olmos D.; Attard G.; De Giorgi U. 2021-01-01 EUROPEAN JOURNAL OF CANCER - 1.01 Articolo in rivista -
Plasma tumor DNA is associated with increased risk of venous thromboembolism in metastatic castration-resistant cancer patients Conteduca V.; Scarpi E.; Wetterskog D.; Brighi N.; Ferroni F.; Rossi A.; Romanel A.; Gurioli G.; ...Bleve S.; Gianni C.; Schepisi G.; Lolli C.; Cortesi P.; Matteucci F.; Barone D.; Paganelli G.; Demichelis F.; Beltran H.; Attard G.; De Giorgi U. 2021-01-01 INTERNATIONAL JOURNAL OF CANCER - 1.01 Articolo in rivista -
Prolonged exposure to (R)-bicalutamide generates a LNCaP subclone with alteration of mitochondrial genome Sara Pignatta;Chiara Arienti;Wainer Zoli;Marzia Di Donato;Gabriella Castoria;Elisa Gabucci;Valent...ina Casadio;Mirella Falconi;Ugo De Giorgi;Rosella Silvestrini;Anna Tesei 2014-01-01 MOLECULAR AND CELLULAR ENDOCRINOLOGY - 1.01 Articolo in rivista -
PSMA expression: A potential ally for the pathologist in prostate cancer diagnosis Bravaccini S.; Puccetti M.; Bocchini M.; Ravaioli S.; Celli M.; Scarpi E.; De Giorgi U.; Tumedei ...M.M.; Raulli G.; Cardinale L.; Paganelli G. 2018-01-01 SCIENTIFIC REPORTS - 1.01 Articolo in rivista -
Sequencing Life-Prolonging Agents in Castration-Resistant Prostate Cancer Patients: Comparison of Sequences With and Without 223Ra. Caffo O, Frantellizzi V, Monari F, Galli L, Costa RP, Pinto C, Tucci M, Baldari S, Facchini G, Bo...rtolus R, Alongi F, Alongi P, Donner D, Fanti S, Sbrana A, Morabito A, Masini C, Zichi C, Pignata S, Borsatti E, Salgarello M, Spada M, De Giorgi U, Lo Re G, Cortesi E, De Vincentis G. 2021-01-01 CANCER BIOTHERAPY & RADIOPHARMACEUTICALS - 1.01 Articolo in rivista -
The cyclin-dependent kinases pathway as a target for prostate cancer treatment: rationale and future perspectives Brighi N.; Conteduca V.; Lolli C.; Gurioli G.; Schepisi G.; Palleschi M.; Mariotti M.; Casadei C....; De Giorgi U. 2021-01-01 CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY - 1.01 Articolo in rivista -